Skip to content
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
We use cookies to ensure that we give you the best experience on our website. By clicking “Ok”, you consent to the use of all cookies.Ok